Advertisement

The Pathobiochemistry of Gastrointestinal Symptoms in a Patient with Niemann-Pick Type C Disease

  • Mahdi Amiri
  • Eva-Maria Kuech
  • Hadeel Shammas
  • Gabi Wetzel
  • Hassan Y. NaimEmail author
Research Report
Part of the JIMD Reports book series (JIMD, volume 25)

Abstract

The molecular basis of gastrointestinal intolerances in a severe case of Niemann-Pick type C disease was analyzed in an intestinal biopsy specimen. The enzyme activities of intestinal sucrase-isomaltase and maltase-glucoamylase are reduced in the patient, while that of lactase is comparable to the control. The association of SI with lipid rafts is reduced in the patient’s biopsy as a consequence of altered composition of membrane microdomains. As association with lipid rafts influences the intracellular transport and the enzyme activities of sucrase-isomaltase and maltase-glucoamylase, these data explain reduced carbohydrate digestion in the intestinal lumen and delineate the effect of deficient cholesterol and sphingolipid homeostasis in development of gastrointestinal symptoms in NPC patients.

Keywords

Lipid Raft Lysosomal Storage Disease Substrate Reduction Therapy Microvillus Membrane NPC1 Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

The authors would like to thank the patient and her family as well as the Clinic of Pediatrics of the University Hospital Bonn, Germany, for donating the biopsy.

During the course of this work Hadeel Shammas was recipient of a Ph.D. scholarship from the German Academic Exchange Service (DAAD), Bonn, Germany.

References

  1. Aguilera-Romero A, Gehin C, Riezman H (2014) Sphingolipid homeostasis in the web of metabolic routes. Biochim Biophys Acta 1841:647–656CrossRefPubMedGoogle Scholar
  2. Alfalah M, Jacob R, Naim HY (2002) Intestinal dipeptidyl peptidase IV is efficiently sorted to the apical membrane through the concerted action of N- and O-glycans as well as association with lipid microdomains. J Biol Chem 277:10683–10690CrossRefPubMedGoogle Scholar
  3. Amiri M, Naim HY (2012) Miglustat-induced intestinal carbohydrate malabsorption is due to the inhibition of alpha-glucosidases, but not beta-galactosidases. J Inherit Metab Dis 35:949–954CrossRefPubMedGoogle Scholar
  4. Amiri M, Naim HY (2014) Long term differential consequences of miglustat therapy on intestinal disaccharidases. J Inherit Metab Dis 37:929–937CrossRefPubMedGoogle Scholar
  5. Banikazemi M, Ullman T, Desnick RJ (2005) Gastrointestinal manifestations of Fabry disease: clinical response to enzyme replacement therapy. Mol Genet Metab 85:255–259CrossRefPubMedGoogle Scholar
  6. Bernstein DL, Bialer MG, Mehta L, Desnick RJ (2010) Pompe disease: dramatic improvement in gastrointestinal function following enzyme replacement therapy. A report of three later-onset patients. Mol Genet Metab 101:130–133CrossRefPubMedGoogle Scholar
  7. Cox T, Lachmann R, Hollak C et al (2000) Novel oral treatment of Gaucher’s disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet 355:1481–1485CrossRefPubMedGoogle Scholar
  8. Dahlqvist A (1968) Assay of intestinal disaccharidases. Anal Biochem 22:99–107CrossRefPubMedGoogle Scholar
  9. Hauri HP, Sterchi EE, Bienz D, Fransen JA, Marxer A (1985) Expression and intracellular transport of microvillus membrane hydrolases in human intestinal epithelial cells. J Cell Biol 101:838–851CrossRefPubMedGoogle Scholar
  10. Jacob R, Naim HY (2001) Apical membrane proteins are transported in distinct vesicular carriers. Curr Biol 11:1444–1450CrossRefPubMedGoogle Scholar
  11. Jacob R, Zimmer KP, Schmitz J, Naim HY (2000) Congenital sucrase-isomaltase deficiency arising from cleavage and secretion of a mutant form of the enzyme. J Clin Invest 106:281–287CrossRefPubMedPubMedCentralGoogle Scholar
  12. Lindner R, Naim HY (2009) Domains in biological membranes. Exp Cell Res 315:2871–2878CrossRefPubMedGoogle Scholar
  13. Maiuri L, Raia V, Potter J et al (1991) Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia. Gastroenterology 100:359–369CrossRefPubMedGoogle Scholar
  14. Nichols BL, Avery S, Sen P, Swallow DM, Hahn D, Sterchi E (2003) The maltase-glucoamylase gene: common ancestry to sucrase-isomaltase with complementary starch digestion activities. Proc Natl Acad Sci U S A 100:1432–1437CrossRefPubMedPubMedCentralGoogle Scholar
  15. Parkinson-Lawrence EJ, Shandala T, Prodoehl M, Plew R, Borlace GN, Brooks DA (2010) Lysosomal storage disease: revealing lysosomal function and physiology. Physiology (Bethesda) 25:102–115CrossRefGoogle Scholar
  16. Patterson MC, Vanier MT, Suzuki K et al (2001) Niemann-Pick disease type C: a lipid trafficking disorder. In: Scriver CR, Beaudet AL, Sly WS et al (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3611–3634Google Scholar
  17. Rosenbaum AI, Maxfield FR (2011) Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches. J Neurochem 116:789–795CrossRefPubMedPubMedCentralGoogle Scholar
  18. Wetzel G, Heine M, Rohwedder A, Naim HY (2009) Impact of glycosylation and detergent-resistant membranes on the function of intestinal sucrase-isomaltase. Biol Chem 390:545–549CrossRefPubMedGoogle Scholar

Copyright information

© SSIEM and Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Mahdi Amiri
    • 1
  • Eva-Maria Kuech
    • 1
  • Hadeel Shammas
    • 1
  • Gabi Wetzel
    • 1
  • Hassan Y. Naim
    • 1
    Email author
  1. 1.Department of Physiological ChemistryUniversity of Veterinary Medicine HannoverHannoverGermany

Personalised recommendations